ERBB2 and neoplasm: A fully humanized monoclonal antibody specific for a different HER2 epitope than trastuzumab, pertuzumab binds the extracellular dimerization subdomain of HER2, preventing it from interacting with other members of the HER family and thereby inhibiting tumor cell growth.